drugset / Trial / NCT00659919

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

NCT00659919

Phase 4 Completed 13 enrolled BeerYaakov Mental Health Center
RandomizedCrossoverDouble-blindTreatment

Summary

Administration of trazodone for the treatment of neuroleptic induced acute akathisia in a cross-over fashion of 6 days duration. 3 days of placebo and 3 days of trazodone.

Timeline

Start
2000-11
Primary completion
2003-12
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Trazodone Small molecule

Indications